Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Go back to Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026
(NASDAQ: IOVA) Delayed: 4.36 +0.30 (7.39%)
Previous Close $4.06    52 Week High
Open $4.00    52 Week Low
Day High $4.41    P/E N/A 
Day Low $3.99    EPS
Volume 7,260,536